Find a TenderAwardedContract details notice
Published 22 May 2025, 09:34 BST

Official UK procurement notice

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

Official notice

Authority: NHS England (Central government)

Framework agreement2 lotsGoodsOpen procedureAbove thresholdSME suitable
Framework ceiling (notional)£877,670,570envelope for 2 lots · framework ceiling, not attributable revenue · 2 value updates
Submissions closed 17 Apr 2026awarded 15 Jun 2026
Award (standstill) to ACCORD-UK LTD +8 more2 awards
Framework period 2 yrsends 31 Aug 2028 · up to 31 Aug 2030 with extensions · starts 1 Sept 2026

What is being bought2 lots · detail below

Published requirement description

NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East.

Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.

Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

CPV: Pharmaceutical products

How this framework works

From the published notice
Type
Open framework
Call-offs
every call-off is a further competition among the appointed suppliers
Bids received
25 bids on the busiest of 2 lots · 25 suppliers appointed
Framework period
2 yrs · up to 4 yrs from 1 Sept 2026
Who may buy through it

Please refer to Document No. 09 of the ITO Documents for the list of Participating Authorities/Pharmacy Purchasing Points

Published description of the framework

Please refer to the ITO Documents for the Operation Description

Lots and requirements (2)Procurement structure

2 lots · all with a published value
Lot #1CM/PHR/25/5730/01 - Tranche B for NOFE and MAEAwardedRenewal 2 yrsSMEPublished value£846,138,512

Lot 1 - Tranche A for the North of England and Midlands & East.

Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.

Contract period: 1 Sept 2026 – 31 Aug 2028 (2 yrs) · up to 31 Aug 2030 with extensionsValue: £846,138,512 exc. VAT · £1,015,366,214 inc. VAT
Extensions: CM/PHR/25/5730/01 – Lot 1 – Tranche A for North of England and Midlands & East 01/09/2026 – 31/08/2028 (24 Months) with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. · With an option or option(s) to extend for a further 24 months.
Lot #2CM/PHR/25/5730/02 - Natalizumab for London & SOFEAwardedRenewal 1 yrSMEPublished value£31,532,058

Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement : 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Contract period: 1 Sept 2026 – 31 Aug 2027 (1 yr) · up to 31 Aug 2028 with extensionsValue: £31,532,058 exc. VAT · £37,838,470 inc. VAT
Extensions: CM/PHR/25/5730/01 – Lot 1 – Tranche A for North of England and Midlands & East 01/09/2026 – 31/08/2028 (24 Months) with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. · With an option or option(s) to extend for a further 12 months.

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “NHS Branded Medicines Tranche A - NOFE and Midlands & East and…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use the vehicle
Please refer to Document No. 09 of the ITO Documents for the list of Participating Authorities/Pharmacy Purchasing Points
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
22 May 2025, 09:34 BST
Last source update
21 Jul 2026, 11:16 BST
Award evaluation window
Submission end – 5 Jun 2026
Authority reference
C414060
FTS notice number
2026/S 000-023990
Latest notice
Contract details notice (UK7)
Classification (CPV)
Pharmaceutical products
Delivery area
North East (UKC)North West (UKD)Yorkshire & Humber (UKE)East Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)
+1 moreSouth West (UKK)
Official registry OCID
ocds-h6vhtk-051c98 Find a Tender

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Appointment period ends
17 Apr 2026, 13:00 BST
Clarification deadline
10 Apr 2026, 17:00 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗

Additional info obtained from the abovementioned address. Tenders must be submitted to the abovementioned address

Timeline

22 May 2025 → 1 Sept 2026 · 11 dates
  1. Planning notice published
    22 May 2025, 09:34 BST
  2. Market engagement260 days ago
    28 Jan 2026, 23:59 GMT

    NHS England is advising suppliers of an upcoming tender for the NHS Branded Framework Agreement – Tranche A for the North of England and Midlands & East.

    Period of Framework Agreement (Lot 1): 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.

    There will be a separate Lot to provide framework agreement coverage to the London and South of England regions for Natalizumab. The period of Framework Agreement (Lot 2): 1st September 2026 to 31st August 2027 with the option or option(s) to extend for a further 12 months.

    Eight category areas are covered in Tranche A: Erythropoietin Stimulating Agents, Granulocyte-Colony Stimulating Factor (GCSF), Insulin Analogues, MS Drugs, Parenteral Iron, Severe Asthma, Severe Asthma/Interleukin Inhibitor and Teriparatide.

    The purpose of this notice is to inform existing and potential new suppliers that if NHS England believe that it would be beneficial a virtual 1:1 preliminary market meeting can be arranged. Please contact [email protected] to register your interest. There will also be a 14 day window for queries to be raised via Atamis after all sessions have concluded.

  3. Tender notice published213 days ago
    17 Mar 2026, 12:14 GMT
  4. Next notice expected212 days ago
    17 Mar 2026, 23:59 GMT
  5. Clarification questions by189 days ago
    10 Apr 2026, 17:00 BST
  6. Admission / appointment period ends182 days ago · period end, not a bid countdown
    17 Apr 2026, 13:00 BST
  7. Award decision expected by132 days ago
    5 Jun 2026, 23:59 BST
  8. Assessment summaries sent115 days ago
    23 Jun 2026, 00:00 BST
  9. Standstill ends105 days ago
    2 Jul 2026, 23:59 BST
  10. Latest notice published87 days ago
    21 Jul 2026, 11:16 BST
  11. Contract starts45 days ago
    1 Sept 2026, 00:00 BST

Notice history

15 events · 8 releases on Find a Tender · since 22 May 2025
  1. Pipeline notice published
    22 May 2025, 09:34 BST
    UK1
  2. Pipeline notice published
    3 Jun 2025, 12:41 BST
    UK1
  3. Preliminary market engagement notice published
    13 Jan 2026, 09:57 GMT
    UK2
  4. Published value updated to £456,000,000
    13 Jan 2026, 09:57 GMT
    was £206,835,684
  5. Preliminary market engagement notice published
    13 Mar 2026, 15:08 GMT
    UK2
  6. Tender notice published
    17 Mar 2026, 12:14 GMT
    UK4
  7. Published value updated to £877,670,570
    17 Mar 2026, 12:14 GMT
    was £456,000,000
  8. Status changed to active
    17 Mar 2026, 12:14 GMT
  9. Procurement method changed
    17 Mar 2026, 12:14 GMT
  10. Deadline published: 17 Apr 2026, 13:00 BST
    17 Mar 2026, 12:14 GMT
  11. Contract award notice published
    23 Jun 2026, 12:33 BST
    UK6
  12. Status changed to complete
    23 Jun 2026, 12:33 BST
  13. Contract signature expected
    6 Jul 2026, 23:59 BST
    scheduled
  14. Contract award notice published
    9 Jul 2026, 15:45 BST
    UK6
  15. Contract details notice published
    21 Jul 2026, 11:16 BST
    UK7
Published amendments (2)

Updated to Above Threshold Tender

Date for Tender Registration Updated

Routine re-releases (8)
  • 2026-03: 2 releases · 13 Mar 2026, 17 Mar 2026
  • 2026-01: 1 release · 13 Jan 2026
  • 2025-06: 1 release · 3 Jun 2025
  • 2025-05: 1 release · 22 May 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 254 awards · see the list ↓
Bids received 256 from SMEs · busiest of 2 lots
Named bidders 25published on the award notice
Contracts signed 2latest 6 Jul 2026
Awarded toValueDateStatus
Lot 1 · CM/PHR/25/5730/01 - Tranche B for NOFE and MAE1 award
ACCORD-UK LTD, Biogen Idec Ltd, Cipla EU Limited, GLAXOSMITHKLINE UK LIMITED, Gedeon Richter UK Ltd, Novo Nordisk Limited +19 moreLot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & East1 Sept 2026 – 31 Aug 2028 · up to 31 Aug 2030Extensions: With an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months · Options: With an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 · Amended: Lot 1 Tender Values Incorrect£665,389,58815 Jun 2026standstill to 2 Jul 2026Standstill
Lot 2 · CM/PHR/25/5730/02 - Natalizumab for London & SOFE1 award
Biogen Idec Ltd, SandozLot 2 - CM/PHR/25/5730/02 - Natalizumab for London & South of England1 Sept 2026 – 31 Aug 2027 · up to 31 Aug 2028Extensions: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months · Options: With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months · Amended: Lot 1 Tender Values Incorrect£35,312,54815 Jun 2026standstill to 2 Jul 2026Standstill

Contracts

  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE

    Signed
    6 Jul 2026
    Value
    £665,389,588
    Period
    1 Sept 2026 – 31 Aug 2028 · up to 31 Aug 2030 with extensions
    Status
    active
    Extensions
    With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
    Options
    With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
  • Lot 2 - CM/PHR/25/5730/02 - Natalizumab for London and South of England

    Signed
    6 Jul 2026
    Value
    £35,312,548
    Period
    1 Sept 2026 – 31 Aug 2027 · up to 31 Aug 2028 with extensions
    Status
    active
    Extensions
    With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
    Options
    With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · CM/PHR/25/5730/01 - Tranche B for NOFE and MAE25final-stage tenders60—
2 · CM/PHR/25/5730/02 - Natalizumab for London & SOFE2final-stage tenders00—

Who bid

Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY Wellington House, 133-135 Waterloo Rd, London, London, SE1 8UGContact name, email

Framework contractors & participating bidders

27 commercial parties on the notice
  • ACCORD-UK LTDFramework contractorGB-PPON: PBTN-3137-DHTG Whiddon Valley, Devon, South West, EX32 8NSContact email
  • AMGEN LIMITEDFramework contractorGB-PPON: PDJG-8184-TCQQ 216 Cambridge Science Park, Cambridge, East of England, CB4 0WAContact email
  • AVENTIS PHARMA LIMITED t-a SanofiFramework contractorGB-PPON: PMBG-8218-QDPT 410 Thames Valley Park Drive, Reading, South East, RG6 1PTContact email
  • BAYER PLCFramework contractorGB-COH: 00935048 400 South Oak Way, Reading, South East, RG2 6ADContact email
  • BAYER PLCFramework contractorGB-PPON: PWRY-2527-LDRY 400 South Oak Way, Reading, South East, RG2 6ADContact email
  • BIOGEN IDEC LIMITEDFramework contractorGB-PPON: PTGT-3385-PBMQ Building 5 Foundation Park, Maidenhead, South East, SL6 3UDContact email
  • CHUGAI PHARMA LIMITEDFramework contractorGB-PPON: PMQZ-8161-PLDQ Ground Floor, Building 4. Chiswick Park, 566 Chiswick High Road, Chiswick, London, W4 5YEContact email
  • CIPLA (EU) LIMITEDFramework contractorGB-PPON: PRLC-3564-DJDN Dixcart House, Addlestone Road, Addlestone, South East, KT15 2LEContact email
  • CST PHARMA LIMITEDFramework contractorGB-PPON: PBDW-5911-ZDBQ Unit 5-7 Tintagel Way, Walsall, West Midlands, WS9 8ERContact email
  • ELI LILLY & COMPANY LTDFramework contractorGB-PPON: PTTR-3628-HTTN Lilly House, Basingstoke, South East, RG21 4FAContact email
Show 17 more suppliers
  • GEDEON RICHTER (UK) LIMITEDFramework contractorGB-PPON: PVNN-9371-ZTBW 127 Shirland Road, London, London, W9 2EPContact email
  • GLAXOSMITHKLINE UK LIMITEDFramework contractorGB-PPON: PNVC-2547-YXMP 79 New Oxford Street, London, London, WC1A 1DGContact email
  • LABORATORIES JUVISE PHARMACEUTICALSFramework contractorGB-PPON: PMCH-3827-GJZN 169 Boulevard de la Bataille de Stalingrad, VILLEURBANNE, FR, 69100, FRContact email
  • MERCK SERONO LIMITEDFramework contractorGB-PPON: PYQR-6988-GHRW 5 New Square, Feltham, London, TW14 8HAContact email
  • MILPHARM LIMITEDFramework contractorGB-PPON: PCYZ-5538-QLGR 1 Roundwood Avenue , Stockley Park, Uxbridge, London, UB11 1AFContact email
  • NAPP PHARMACEUTICALS LTDFramework contractorGB-PPON: PJJB-3288-JNGG Unit 191 Cambridge Science Park, Cambridge, East of England, CB4 0GWContact email
  • NOVO NORDISKFramework contractorGB-COH: 01118740 3 City Place, Gatwick, South East, RH6 0PAContact email
  • NOVO NORDISKFramework contractorGB-PPON: PQLC-7289-YJVN 3 City Place, Gatwick, South East, RH6 0PAContact email
  • ORIFARM UK LTDFramework contractorGB-PPON: PQPW-1715-PJLT Ground Floor, Suite A2 Breakspear Way, Hemel Hempstead, East of England, HP2 4TZContact email
  • PFIZER LIMITEDFramework contractorGB-PPON: PCQW-3224-CMTG Ramsgate Road, Kent, South East, CT13 9NJContact email
  • PHARMACOSMOS UK LTDFramework contractorGB-PPON: PVYL-1477-WWCH 6th Floor The White Building, Reading, South East, RG1 3ARContact email
  • ROCHE PRODUCTS LIMITEDFramework contractorGB-PPON: PXCG-4172-CHYM 6 Falcon Way, Welwyn Garden City, East of England, AL7 1TWContact email
  • SANDOZ LIMITEDFramework contractorGB-PPON: PNQL-1548-CYBZ Maxis 1, Western Road, Bracknell, South East, RG12 1RFContact email
  • TEVA UK LIMITEDFramework contractorGB-PPON: PWDD-6894-DXRM Ridings Point, Castleford, Yorkshire & Humber, WF10 5HXContact email
  • THORNTON & ROSS LIMITEDFramework contractorGB-PPON: PWYH-6892-QYNN Linthwaite Labs, Manchester Road, Huddersfield, Yorkshire & Humber, HD7 5QHContact email
  • VIATRIS UK HEALTHCARE LTDFramework contractorGB-PPON: PQLZ-4934-WXRZ 20 Station Close, Potters Bar, East of England, EN6 1TLContact email
  • VIFOR PHARMA UK LTDFramework contractorGB-PPON: PTLY-2878-GQMZ 5 New Street Square, London, London, EC4A 3TWContact email

Official documents & specifications (30)

Official links; attachments are not copied

Tender pack and attachments

Show 10 more documents

Notices published for this procedure

Show 3 more notices
  • Preliminary market engagement notice planningPreliminary market engagement noticeUK2Preliminary market engagement notice on Find a Tender
  • Pipeline notice planningPipeline noticeUK1Pipeline notice on Find a Tender
  • Pipeline notice planningPipeline noticeUK1Pipeline notice on Find a Tender

1 further documents are listed in the JSON mirror.